🇺🇸 Filgrastine in United States
34 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 34
Most-reported reactions
- Pyrexia — 5 reports (14.71%)
- Disease Progression — 4 reports (11.76%)
- Pneumonia — 4 reports (11.76%)
- Thrombocytopenia — 4 reports (11.76%)
- Febrile Neutropenia — 3 reports (8.82%)
- Infection — 3 reports (8.82%)
- Lung Infection — 3 reports (8.82%)
- Off Label Use — 3 reports (8.82%)
- Product Use In Unapproved Indication — 3 reports (8.82%)
- Anal Abscess — 2 reports (5.88%)
Other Other approved in United States
Frequently asked questions
Is Filgrastine approved in United States?
Filgrastine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Filgrastine in United States?
Blau Farmaceutica S.A. is the originator. The local marketing authorisation holder may differ — check the official source linked above.